Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after Breast-Conserving Surgery

PURPOSE: Trastuzumab is effective in early and advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, few studies have reported the effect of trastuzumab on ipsilateral breast tumor recurrence (IBTR), whose incidence is higher in the HER2-positive subtype than in o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Breast Cancer
Hlavní autoři: Cheun, Jong-Ho, Won, Jiyoung, Jung, Ji Gwang, Kim, Hong-Kyu, Han, Wonshik, Lee, Han-Byoel
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Breast Cancer Society 2021
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8250103/
https://ncbi.nlm.nih.gov/pubmed/34190441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2021.24.e33
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky